Review Article
[Retracted] Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
Table 2
Targeting signaling in the treatment of HCC and phases of trials.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HGF = hepatocyte growth factor; FGF = fibroblast growth factor; MAB = monoclonal antibody; PDGF = platelet-derived growth factor; PDGF(R) = platelet-derived growth factor receptor; VEGF = vascular endothelial growth factor; and VEGF(R) = vascular endothelial growth factor receptor. |